Cigna Group $CI Shares Bought by Principal Financial Group Inc.

Principal Financial Group Inc. raised its holdings in Cigna Group (NYSE:CI) by 4.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 304,736 shares of the health services provider’s stock after purchasing an additional 13,798 shares during the quarter. Principal Financial Group Inc.’s holdings in Cigna Group were worth $83,872,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Beacon Financial Strategies CORP acquired a new stake in shares of Cigna Group during the 4th quarter worth about $28,000. Lodestone Wealth Management LLC acquired a new position in Cigna Group in the fourth quarter valued at about $32,000. Collier Financial purchased a new stake in shares of Cigna Group in the 3rd quarter valued at approximately $34,000. Activest Wealth Management lifted its holdings in shares of Cigna Group by 1,050.0% in the 4th quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock worth $38,000 after acquiring an additional 126 shares during the last quarter. Finally, True Wealth Design LLC boosted its position in shares of Cigna Group by 116.4% during the fourth quarter. True Wealth Design LLC now owns 158 shares of the health services provider’s stock worth $43,000 after buying an additional 85 shares during the period. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Cigna Group

In other news, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the transaction, the insider owned 5,670 shares in the company, valued at $1,638,119.70. This represents a 23.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is currently owned by insiders.

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $283.76 on Friday. Cigna Group has a one year low of $239.51 and a one year high of $338.89. The business has a 50-day simple moving average of $274.29 and a 200-day simple moving average of $276.32. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The company has a market cap of $75.06 billion, a PE ratio of 12.03, a P/E/G ratio of 0.99 and a beta of 0.30.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period in the previous year, the company earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities research analysts forecast that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be issued a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Guggenheim boosted their price objective on Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a report on Monday. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Jefferies Financial Group reduced their price target on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a research report on Monday, April 20th. Piper Sandler dropped their price objective on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. Finally, Leerink Partners increased their target price on shares of Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a report on Friday, February 6th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and an average price target of $338.35.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.